Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
31
GFS Quote, Financials, Valuation and Earnings
Last price:
$38.67
Seasonality move
:
-9.91%
Day range:
$37.64 - $39.34
52-week range:
$35.85 - $61.98
Dividend yield:
0%
P/E ratio:
29.93x
P/S ratio:
3.19x
P/B ratio:
1.99x
Volume:
1.8M
Avg. volume:
2.6M
1-year change:
-25.33%
Market cap:
$21.4B
Revenue:
$6.8B
EPS (TTM):
-$0.48
Analysts' Opinion
-
Consensus RatingGLOBALFOUNDRIES has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 8 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $47.81, GLOBALFOUNDRIES has an estimated upside of 23.4% from its current price of $38.74.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $38.00 representing 100% downside risk from its current price of $38.74.
Fair Value
-
According to the consensus of 17 analysts, GLOBALFOUNDRIES has 23.4% upside to fair value with a price target of $47.81 per share.
GFS vs. S&P 500
-
Over the past 5 trading days, GLOBALFOUNDRIES has underperformed the S&P 500 by -3.83% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
GLOBALFOUNDRIES does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
GLOBALFOUNDRIES revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter GLOBALFOUNDRIES reported revenues of $1.8B.
Earnings Growth
-
GLOBALFOUNDRIES earnings have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter GLOBALFOUNDRIES reported earnings per share of -$1.32.
Enterprise value:
19.9B
EV / Invested capital:
1.57x
Price / LTM sales:
3.19x
EV / EBIT:
27.30x
EV / Revenue:
2.94x
PEG ratio (5yr expected):
--
EV / Free cash flow:
18.12x
Price / Operating cash flow:
19.63x
Enterprise value / EBITDA:
8.66x
Gross Profit (TTM):
$1.7B
Return On Assets:
-1.49%
Net Income Margin (TTM):
-3.93%
Return On Equity:
-2.39%
Return On Invested Capital:
-1.99%
Operating Margin:
12.84%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $8.1B | $7.4B | $6.8B | $1.9B | $1.8B | |
| Gross Profit | $2.2B | $2.1B | $1.7B | $525M | $449M | |
| Operating Income | $1.3B | $1.2B | $728M | $333M | $235M | |
| EBITDA | $3.2B | $2.6B | $2.3B | $720M | $613M | |
| Diluted EPS | $2.63 | $1.84 | -$0.48 | $0.50 | -$1.32 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $5.3B | $5.8B | $6.3B | $6.4B | |
| Total Assets | $12.3B | $15B | $17.8B | $18B | $16.8B | |
| Current Liabilities | $1.9B | $3.2B | $3.4B | $3.1B | $3B | |
| Total Liabilities | $5.1B | $7B | $7.9B | $6.9B | $6B | |
| Total Equity | $7.2B | $8B | $10B | $11.2B | $10.8B | |
| Total Debt | $2.3B | $2B | $2.5B | $2.4B | $1.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.6B | $2.1B | $1.7B | $684M | $457M | |
| Cash From Investing | -$4.1B | -$1.9B | -$1.1B | -$95M | -$92M | |
| Cash From Financing | $842M | -$212M | -$785M | -$87M | -$452M | |
| Free Cash Flow | -$435M | $321M | $1.1B | $456M | $322M | |
GFS
Sector
Market Cap
$21.4B
$91.6M
Price % of 52-Week High
62.5%
60%
Dividend Yield
0%
0%
Shareholder Yield
1.24%
0.82%
1-Year Price Total Return
-25.33%
-15.91%
Beta (5-Year)
--
0.910
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$37.97
200-day SMA
Sell
Level
$44.02
Bollinger Bands (100)
Sell
Level
39.16 - 44.1
Chaikin Money Flow
Sell
Level
-8.6M
20-day SMA
Sell
Level
$40.07
Relative Strength Index (RSI14)
Sell
Level
46.80
ADX Line
Sell
Level
16.29
Williams %R
Neutral
Level
-54.8043
50-day SMA
Sell
Level
$40.94
MACD (12, 26)
Sell
Level
-1.09
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
15.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0615)
Buy
CA Score
(Annual)
Level (0.4624)
Buy
Beneish M-Score
(Annual)
Level (-2.3625)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-4.5226)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and employs about 13,000 people.
Stock Forecast FAQ
In the current month, GFS has received 7 Buy ratings 8 Hold ratings, and 2 Sell ratings. The GFS average analyst price target in the past 3 months is $47.81.
-
Where Will GLOBALFOUNDRIES Stock Be In 1 Year?
According to analysts, the consensus estimate is that GLOBALFOUNDRIES share price will rise to $47.81 per share over the next 12 months.
-
What Do Analysts Say About GLOBALFOUNDRIES?
Analysts are divided on their view about GLOBALFOUNDRIES share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GLOBALFOUNDRIES is a Sell and believe this share price will drop from its current level to $38.00.
-
What Is GLOBALFOUNDRIES's Price Target?
The price target for GLOBALFOUNDRIES over the next 1-year time period is forecast to be $47.81 according to 17 Wall Street analysts, 7 of them rate the stock a Buy, 2 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is GFS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for GLOBALFOUNDRIES is a Hold. 8 of 17 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of GFS?
You can purchase shares of GLOBALFOUNDRIES via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GLOBALFOUNDRIES shares.
-
What Is The GLOBALFOUNDRIES Share Price Today?
GLOBALFOUNDRIES was last trading at $38.67 per share. This represents the most recent stock quote for GLOBALFOUNDRIES. Yesterday, GLOBALFOUNDRIES closed at $38.74 per share.
-
How To Buy GLOBALFOUNDRIES Stock Online?
In order to purchase GLOBALFOUNDRIES stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
